Diagnostics Startups
34 companies tagged Diagnostics, with their investors and founders.
Ginkgo Bioworks designs custom engineered organisms for customers across multiple markets, operating foundries that use software and hardware automation to scale the organism engineering process.
34 investors
AOA Dx develops a blood-based liquid biopsy platform using mass spectrometry and machine learning to detect ovarian cancer at early stages through tumor-associated biomarkers in serum. The company serves oncologists and patients in women's health diagnostics.
32 investors
BillionToOne builds a DNA molecular counting technology that increases the resolution of cell-free DNA diagnostics, applied to prenatal screening and liquid biopsy for cancer. Its products serve clinical genetic testing in prenatal care and oncology.
23 investors
Orange Health Labs operates a home-based diagnostic testing service in Indian cities, offering sample collection within 30 minutes and lab results within 6 hours. The company serves urban consumers seeking rapid medical testing across major metropolitan areas.
14 investors
Redcliffe Labs is a diagnostic services company offering doctor-curated health checkup packages, genetic and pathology testing, along with expert consultation, AI assistance, and personalized health guidance. It serves patients across India with accessible, affordable diagnostics, including a women-centric platform.
13 investors
Cofactor Genomics develops predictive diagnostics using RNA data models and Predictive Immune Modeling to build biomarkers, with an initial application predicting which cancer patients will respond to immunotherapy. The company targets oncology diagnostics in the US precision medicine market.
11 investors
Kenota (formerly ExVivo Labs) develops diagnostic technology for disease testing. The company operates in the healthcare and diagnostics industry.
8 investors
Scout develops portable molecular diagnostic testing devices that deliver lab-grade accuracy in under 30 minutes for point-of-care use. The platform enables healthcare providers to test and treat patients in real-time without requiring lab infrastructure or specialized training.
7 investors
Lucira Health (Diassess Inc.) develops low-cost, disposable diagnostic hardware for infectious disease testing that pairs with smartphones to provide rapid, real-time analysis of bodily fluids. The company targets consumer and clinical health diagnostics.
6 investors
Yemaachi creates a diverse cancer bio-database to develop oncology drugs effective across diverse patient populations. The company develops precision oncology research, diagnostics, and therapeutics with a focus on inclusion for global communities.
6 investors
Darmiyan develops brain-analysis technology for early detection of Alzheimer's disease. Its first product, BrainSee, aims to identify the disease at an early stage.
5 investors
Delee is a medical device company that makes a blood-testing device for early cancer diagnosis and treatment monitoring by isolating and analyzing circulating tumor cells.
5 investors
InVision Medtech develops AI software that automatically evaluates left ventricular ejection fraction from echocardiographic images for cardiologists and medical facilities. The product has demonstrated time savings and improved clinical precision in a prospective clinical trial published in Nature.
5 investors
Numen develops at-home cancer diagnostics and health data collection infrastructure using machine learning models to enable earlier intervention and improve patient outcomes.
5 investors
Clear Gene develops diagnostic tests used in cancer care that indicate to doctors whether a tumor has been fully removed. The company operates in the oncology and women's health diagnostics space.
4 investors
The Human Diagnosis Project builds an open medical intelligence system that combines input from medical professionals with machine learning to map the steps for diagnosing and helping patients. It aims to make care more accurate, affordable, and accessible.
4 investors
One Codex operates a data platform for applied microbial genomics and metagenomics, supporting applications in clinical diagnostics, food safety, and biosecurity. The company was acquired by Invitae in 2021 and spun out as independent in 2022.
4 investors
PNOĒ makes a clinical-grade breath analysis (metabolic/VO2max testing) device paired with software and expert support that produces personalized nutrition, exercise, breathwork, and bio-optimization programs. It is sold to health professionals and clinics to assess clients' metabolic and cardiovascular health and quantify progress.
4 investors
Scanwell Health develops smartphone-enabled, at-home diagnostic tests that let people test themselves and receive same-day results for acute illnesses, chronic diseases, and rare conditions. Its first product is an FDA-cleared over-the-counter app for testing and treating urinary tract infections.
4 investors
Signatur Biosciences develops molecular diagnostic solutions using qPCR technology for in vitro diagnostics, targeting clinical and laboratory markets. The company aims to deliver advanced diagnostics on widely available instrumentation to expand access to cutting-edge healthcare globally.
4 investors
Isabl develops whole genome and transcriptome sequencing technology for cancer diagnosis, delivering comprehensive genomic profiling and treatment options to physicians and research teams. The company provides rapid cancer diagnostic tests in clinically relevant timeframes to improve outcomes for cancer patients globally.
3 investors
Moichor is an animal diagnostics laboratory providing automated blood count and cytology testing for veterinarians across the United States. The company uses artificial intelligence and computer vision to deliver species-specific pathology results through both send-in laboratory services and an in-clinic hematology device.
3 investors
Spot provides white-label at-home diagnostic testing services for health brands, enabling users to collect and submit lab-analyzed blood, urine, and saliva samples at home. The platform handles sample collection kits, regulatory compliance including doctor orders where required, lab partnerships, and integration of results into customer-facing applications.
3 investors
Adravision builds a shared intelligence platform that integrates fragmented dental information systems, connecting clinical records, radiographs, treatment plans, and insurance data to support care delivery, documentation, and reimbursement.
2 investors






















